Research Project

Project Title:	Efficacy and Safety of SGLT2-i in Fanconi Bickel Syndrome, ERKNET and MetabERN join project
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Metabolic & stone disorders
Project Summary:	In February 2025, we launched a call between all ERKNET and MetabERN members to discuss the recent evidences on the use of SGLT2-i in FBS. We collect the experience of several colleagues from allover the world and we plan to make a new call in 9 months. This aims to set up a database collection of the patients in treatment from at least 1 year. We are trying to make a common webpage between the ERKreg and the correspondent registry from MetabERN in order to collect the data with accurancy.
Lead principal investigator(s):	Francesco Trepiccione, Naples
Co-investigator(s):	Derks Terry, Naples
Project Period:	02/2025 - 02/2026
Sponsors:	Local resources